Abstract: Cyclic esters and amides (lactones and lactams) are important active ingredients and polymerb uilding blocks. In recent years, numerous biocatalytic methods for their preparation have been developed including enzymatic and chemoenzymatic Baeyer-Villiger oxidations, oxidative lactonisation of diols,a nd reductive lactonisation and lactamisation of ketoesters.T he currents tate of the art of these methods is reviewed.
Introduction
Lactones and lactams represent two very diverse product classes widespread in natural products,a ctive pharmaceutical ingredients, cosmetics, flavours and fragrances. In addition, lactones and lactamsa re important building blocks in the synthesis of polyesters and polyamides. [1] Hence, it is not very astonishing that today's organic chemistry toolbox is well filled with synthetic procedures for their synthesis.
In recent years, their synthesis also caught the attention of biotechnologists resulting in ar ichp ortfolio of biocatalytic alternatives complementing the existing chemical ones. The promise of these methods lies with the (suspected) environmental benignity of biocatalysis and -more importantly-with the intrinsic selectivity of enzymes. Hence, biocatalysis in principle offers more selectiver outes yielding products of higher quality in fewer process steps.
The aim of this contribution is to critically summarise the current state of the art of this dynamically developing field.
The major biocatalytics ynthesis strategies
At present,t here are three major biocatalytic routes for the synthesis of lactones:( 1) Baeyer-Villiger oxidations, (2) oxidative lactonisations of diols and (3) the reductivec yclisation of g-a nd d-ketoesters. In the following these methods will be briefly outlined.
For the biocatalytic Baeyer-Villiger oxidation,t wo very different enzyme classes are at hand:the Baeyer-Villiger monooxygenases (BVMOs) and hydrolases following the so-calledp erhydrolase pathway.
BVMOs activate molecular oxygen within the enzymes' active sites as organic peroxide, whicht hen attacks the carbonyl group forming the lactone product and water.F or the reductivea ctivation of O 2 BVMOs utilise reduced nicotinamide cofactors (NADH or NADPH) (Scheme 1). Very similart ot he chemicalB aeyer-Villiger oxidation, the BVMO oxidation proceeds via the so-called Criegee intermediate. In contrast to the chemicalr eaction, the migration tendency of the two substituents of the carbonyl group is not only determined by their chemicalr eactivity but can also be influenced by the amino acids in the enzyme actives ite. Hence, BVMO-catalysed Baeyer-Villiger oxidations very frequently give access to complementary products as compared to their chemical counterparts. Furthermore,B VMO-catalysed Baeyer-Villiger oxidations proceedh ighly enantiospecific and enantioselective, making them valuablet ools for the synthesis of enantiomerically pure lactones.
One consequence of the catalytic mechanism of BVMOs is that these enzymes depend on the constant, stoichiometric supplyo fr educing equivalents in form of the reduced, natural nicotinamide adenine dinucleotide cofactor (NADH or NADPH). The high cost of this cofactor prevents anyc ommerciala pplication in stoichiometric amounts. Fortunately,t oday,ab road range of in situ regeneration systemsf or the reduced nicotinamide cofactor are available allowing for its use in catalytic amounts(vide infra).
As mentioned above,t he catalytic mechanism of the hydrolase-mediated Baeyer-Villiger oxidation differs significantly from the mechanism of the above-described BVMOs.H ydrolase-mediated Baeyer-Villiger oxidations comprise at wo-step, chemoenzymatic reaction mechanism (Scheme 2). In the first step, carboxylic acid (esters) are transformed into their percarboxylic acid derivates.T his reaction is facilitated by the socalled perhydrolase activity of many hydrolases. The resulting percarboxylic acid then performs the classical Baeyer-Villiger oxidation.
The chemoenzymatic nature of this reaction also entails that none of the selectivity advantages of biocatalytic reactions can be expected for this approach. Possibly, using enantiomerically pure carboxylic acids may overcomet his limitation.
Oxidative lactonisations of diols have been reported mostly using alcohold ehydrogenases (ADHs) as catalysts. ADHs catalyse the reversible, NAD(P)
+ -dependent abstraction of ah ydride equivalent from OH-substituted CÀH-bonds.I nc ase of 1,4-or 1,5-diols, the primarily formed aldehyde can undergo spontaneous cyclisation leading to ah emiacetal (lactol), which itself can be oxidised once again by the ADH (Scheme 3).
Again, the issue of NAD(P)
+ costs and their use in catalytic amountsa rises. But again this challenge can, in principle, be considered to be solved through the use of established in situ regeneration systemsfor oxidized nicotinamide cofactors.
Finally,t he reductive cyclisation of g-a nd d-ketoesters is worth being discussed here. In this approach, reduction or reductive amination of the keto group in g-a nd d-ketoesters leads to g-a nd d-hydroxy-or amino esters, which spontaneously and irreversiblyc yclise to the corresponding lactones or lactams, respectively (Scheme4). 
Biocatalytic Baeyer-Villiger oxidations using BVMOs

Mechanistic considerations
BVMOs are flavin containing enzymes. The catalytically active speciesi sadeprotonated peroxoflavin, which is formed in a sequence of NAD(P)H-dependent reduction of the restings tate (oxidised) flavin group and reductivea ctivation of molecular oxygen (Scheme 5). The latter then nucleophilically attacks the carbonyl group of the substrate forming the Criegee intermediate. In contrastt ot he chemical reaction, the migration tendency of the two substituentso ft he carbonyl group is not only determined by their chemical reactivity but can also be influenced by the active site architecture of the enzyme. Hence, BVMO-catalysed Baeyer-Villiger (BV) oxidations very frequently give access to complementary products as compared to their chemical counterparts.
Sourcesfor BVMOs and new, improved BVMOs
Despite the early realisation that ab iological counterpart to BV-oxidation occurs in microorganisms, the discovery and cloning of cyclohexanonem onooxygenase (CHMO) and the subsequent studies into the substrate scope and selectivity and specificity of CHMO truly realised the synthetic potentialo f BVMOs.I nr ecent years the number of availableB VMOs has expanded significantly and now includes several eukaryotic BVMOs from fungi, [2] moss and algae. [3] In addition to the ever growingc ollection of BVMOs,c onsiderable effort into the directed evolution of several BVMOs has furthere xpanded their substrate scope and improved or alteredt heir stereoselectivity/specificity. [4] Despite the widespread use of CHMO, the practical application of this BVMO (and many others) remains limited due to its operational and thermal instability.V arious researchers have therefore focusedo ni mproving the stabilityo fC HMO through rational design and directed evolution.
[5] Until recently,p henylacetonem onooxygenase (PAMO) wast he only truly stable BVMO. Unfortunately PAMO displays ar ather narrows ubstrate scope and is unreactivewith most of the cyclic ketonesaccepted by CHMO, limiting its use for lactone synthesis. Again, evolution studies were able to expand the substrate scope of PAMO to include cyclic ketones such as cyclohexanone [6] and 2-phenylcyclohexanone.
[7] The discovery of new,m ore stable BVMOss uch as PockeMO [2a] from Thermothelomyces thermophile and TmCHMO [8] from Thermocrispum municipal will potentially greatly improve practical applicationso fB VMOs in lactone synthesis.
Practicalissues for the application of BVMOs
Some issues frequently observed using BVMOs are (1) their dependency on the reduced nicotinamide cofactors and (2) inhibitory effects of the reagents (substrates and products).
The "cofactorc hallenge"p articularly concerns Baeyer-Villiger oxidations using cell-free BVMOs. This general limitation to oxidoreductases has been known for decades [9] resulting in a broad range of in situ NAD(P)H regeneration systems. Obviously "the usual suspects" such as formate dehydrogenase (FDH) or glucose dehydrogenase (GluDH)c an be applied as in situ NAD(P)H regeneration systems. More elegantly,h owever,s equentialc ascades employing alcohold ehydrogenases (ADHs) and BVMOs enabler edox-neutral transformation of lactones from the corresponding alcohols without using any auxiliary cosubstrates for example, glucoseorf ormic acid (Scheme 6).
Reported first as early as the 1990s, [10] this approach is now receiving renewed attentionb yv arious groups envisioning the cost-efficient synthesis of lactoneb uilding blocks for polyesters.
[11] Next to this sequential,r edox-neutral cascade some of us have recently developed ac onvergent analogue (vide infra).
In vivo reactions, that is, BVMO reactions using whole, metabolically active cells are also enjoying great popularity particularly because no additional cofactors have to be supplied since the microbial metabolism providest he reduced nicotinamide cofactors needed for catalysis. [12] Inhibitory effects of substrates and products are frequently observed in BVMO-catalysed reactions. While substrate inhibition can be addressed by as ubstrate feeding strategy, [13] prod- [13a,b] as well as hydrophobic organic solvents. [14] To overcome the product inhibition observed with e-caprolactone, researchers have used lipases to remove the inhibiting lactone. For example, lipase A( CalA) from Candida antarctica oligomerises e-caprolactone [15] whereas CalB can be employed for the hydrolysis of the lactone to 6-hydroxyhexanoic acid.
[16]
BVMO-catalysed oxidations
The substrate scope of BVMOs hasn ow grownt oi nclude simple cyclic ketones from cyclobutanone to cylopentadecanone, highly substituted cyclic ketones including various monoterpenones, fused and bridged bicyclic ketones to various steroids(Scheme 8).
[17]
As mentioned above,o ne of the major advantageso f BVMO-catalysis for the oxidative lactonisation of (cyclo)ketones is the ability to form both the normal and the (chemically disfavoured) "abnormal" lactone, depending on which BVMO is used (Scheme 9).
Nowadays, numerous BVMOs and evolved variants are available and regiocomplementary reactions from the same starting materialare often possible. [18] One of the most often used substrates to evaluate the activity of BVMOs is rac-(cis)-bicyclo[3.2.0]hept-2-en-6-oneo fw hich the products are important chiral synthons in prostaglandin synthesis. This seemingly universal substrate for BVMOsc an simultaneously assess the ability of BVMOs for regiospecificity as well as enantioselectivity (Scheme 10).
Cyclohexanone monooxygenase (CHMO), for example performs the regiodivergent conversion of rac-(cis)-bicyclo[3.2.0]-hept-2-en-6-one with the (1R,5S)e nantiomer being transformed into the normal lactonew hereas the (1S,5R)e nantiomer is transformed into the abnormal lactone. [19] Other BVMOs such as MO14f rom Rhodococcus jostii shows high enantioselectivity for the racemate resulting in kinetic resolutions (KRs) yieldingt he enantiomerically pure normall actoneo ft he (1R, 5S)e nantiomer while leaving the (1S,5R)-ketone in 96 % ee. [20] Similar kinetic resolutions have been shown with other BVMOs as well as the ability to obtain the abnormal lactone (1S,5R)i n high ee.
[2c]
The popularity of rac-(cis)-bicyclo[3.2.0]hept-2-en-6-one as model substrate also explainsi tp revalence as startingm aterial in preparative-scale BVMO oxidations (Table 1) .
Further examples of KRs using BVMOs include p-alkene cyclohexanone derivates [24] or dihydrocarvone.
[4b] The intrinsic Scheme7.Common product removal strategies to alleviate inhibitory effects on BVMOs. A: in situ extraction of the product into ahydrophobic organic phase or to aresin;B:hydrolysis or oligomerisation of the lactone product.
Scheme8.Representation of the wide substrate scope of BVMOs.
Scheme9.Use of complementary BVMOs (from natural or man-made diversity) to produce either the 'normal' or the 'abnormal' lactone.
Scheme10. Asymmetric (enantioseletive and regiospecific) oxygenation of rac-(cis)-bicyclo[3.2.0]hept-2-en-6-one by BVMOs. CHMO [22] SF [b] 55 L, 3.5 h 247.5 g, 1gL À1 h À1 1.09 76 %, 210 g CHMO [23] SF [b] 200 L, 7h 900 g, 0. disadvantage of KRs of maximal yields of 50 %i ns ome cases can be overcome using prochiral starting materials such as palkyl cyclohexanones. [25] Another approach is to design dynamic kinetic resolutions (DKRs) where the racemic startingm aterial, next to the enantioselectiveB aeyer-Villiger oxidation also undergoes ar acemisation reaction. Obviously,i nc ase of a-substituted( cyclo)ketones this can be achieved easily by adjusting the pH of the reaction mixture to alkaline values or using anion exchange resins at more ambient pH (Scheme 11). [26] In recent years, embedding BVMO-catalysedr eactions into larger cascade reactions has attracted significant interest. Particularly,i ns itu generation of the cycloketone substrate has been investigated by various groups.F or example, ac ascade comprising ac ytochrome P450 monooxygenase and an ADH yielded cyclohexanonef rom the corresponding cycloalkane (Scheme 12 A); [27] in as imilar redox-neutral approacha llylic alcohols can be transformed into cycloketones (Scheme 12 B). [28] The latter approachr epresents an interesting method to transform limonenew astes (from orange peels)i nto carvolactone as ab uilding block for functional polymers.
Chemoenzymatic oxidations via the perhydrolase approach
Alreadyi nt he 1990s, Bjçrkling and co-workersr eported the so-called perhydrolase reaction of esterases as promiscuous activity of many hydrolases.
[29] Especially serine hydrolases accept nucleophiles other than water or alcohols to hydrolyse the enzyme acyl-intermediate. In case of H 2 O 2 as alternative nucleophile, peracids are formed, which canu ndergo ar ange of oxidative transformations,i ncluding Baeyer-Villiger oxidations (Scheme 2). [30] Compared to the BVMO-catalysed Baeyer-Villiger oxidation, the chemoenzymatic variant bears ar ange of intrinsic advantages making it interesting fori ndustrial application:F irst, this reactiond oes not require any cofactors and corresponding regeneration systems. Second, ab road range of immobilisedh ydrolases are commercially available (though the immobilised lipase from Candida antarctica,t radename Novozyme 435 is by far the most popular). Third, many of these preparations are active and stable under non-aqueous conditions. Especially the latter is of utmost importance to attain high substrate loadings. Ta ble 2g ives ar epresentative, yet incomplete overview of reported chemoenzymatic Baeyer-Villiger oxidations.
Frequently,c oncentrated H 2 O 2 solutions are used to minimise the water concentration. Similarly,a lso urea-H 2 O 2 (UHP) is ap opular( anhydrous) H 2 O 2 source. Nevertheless, even under anhydrous conditions and using UHP,w ater accumulation cannotb ep revented since it constitutes the stoichiometric byproduct. This may lead to hydrolysis of the lactone product. To some extent, this can be overcome by reactione ngineering and/or protein engineering. [34, 36] Under carefully chosen reactionc onditions, this generally undesired side reactionc an, however, also be exploitedf or a combined Baeyer-Villiger oxidation and ring opening polymerisations equence. [37] Another issue necessitating further attentioni nt he future is the poor affinity of hydrolases for H 2 O 2 necessitating high H 2 O 2 concentrations to achieveh igh reactionr ates. Such high H 2 O 2 concentrations (severalh undred millimolar) also lead to oxidative inactivationo ft he enzymes.
Scheme11. DKR of a-substituted ketones at alkaline pH benefittingf rom the highenantioselectvityoft he BVMOfor one enantiomer and the fast racemisation of the starting material. [26a,b] Scheme12. BVMO-catalysed Baeyer-Villiger oxidations with in situ generated cycloketones. A: from cycloalkanes with cytochrome P450 monooxygenase (CYP450)-catalysed hydroxylation followed by ADH-catalysed oxidation or B: from allylic alcohols by ADH-catalysed oxidation and ene reductase (ER)-catalysed reduction. Both pre-cascades as redox-neutral. Envisioning chiral lactone products, the chemoenzymatic approach appears lesss uited as generally racemic products are formed. Ap romisinga pproacht os olve this shortcoming may be to use chiral (per)acids for the chemical Baeyer-Villiger oxidation.U sing methyl-substituted carboxylic acids, Chrobok and co-workersa chieved opticalp urities of up to 96 %i nt he conversion of 4-methyl cyclohexanone. [38] Overall, the perhydrolase approach appears to be an interesting approachf or the preparative scale Baeyer-Villiger oxidation if the optical purity of the products is of lesser importance.
Biocatalytic oxidative lactonisations 4.1. ADH-catalysed reactions
The oxidative lactonisation of (mostly 1,4-and 1,5-) diols is a double oxidation process. In the first step one alcoholf unctionality is oxidised to the corresponding aldehyde,w hich is in equilibrium with the intramolecular hemiacetal (lactol). The latter can be oxidised once more to the desired lactone product (Scheme 3).
The first example for an ADH-catalysedv ersion of this reaction sequence was reported as early as 1977b yJ ones and coworkers.
[39] Since the ADH-oxidation steps are principally stereospecific, often enantiomerically pure lactone products are obtained either via kineticr esolution of racemic diol starting materialso ru sing the meso-trick. Later the same group also demonstrated the preparative applicability of this approach. [40] Since thesep ioneering works, other groups have further contributed to the development and application of this reaction system. Ta ble 3g ives ar epresentative overview of products reported from ADH-catalysed oxidative lactonisations.
As cofactor-dependentr eactions, ADH-catalysed oxidative lactonisations necessitate efficient in situ NAD(P) + regeneration systems. Jones and others used asimple aerobic regeneration system with flavins as NAD(P)H oxidation catalysts.
[39- 40, 42, 45] The first oxidations tep [that is, the hydride transfer from NAD(P)H to flavin mononucleotide (FMN)] is painfully slow necessitatingh igh concentrationso ft he flavin "catalyst" and requiring long reactiont imes. This can be alleviated very significantly by photochemical activation of the flavin catalyst.
[46] Also other catalysts can be used to reoxidise NAD(P)H such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonica cid) (ABTS).T he resulting reduced ABTS itself can be reoxidised electrochemically [47] or using laccases. [44, 48] Next to cofactor regeneration issues,s ubstrate-and product inhibition as well as undesired hydrolysiso ft he lactone products in aqueous media are also frequently observed. Again, these challenges can be overcome by use of the two-liquidphase-system (2LPS) approach(Scheme 13). [41, 44] Recently,s ome of us combined the aforementioned BVMOcatalysed Baeyer-Villiger oxidation of cycloketones with the ADH-catalysed lactonisationo fd iols to produce lactones in a convergent,r edox-neutral cascade reaction (Scheme14).
[49] The proof-of-concept was first shownf or the synthesis of e-caprolactone up to mg scales. [49b,c] 
Chemoenzymatic reactionsu sing the laccase-TEMPO system
Gotor-Fernµndez and co-workers explored an interesting chemoenzymatic alternative to the above-mentioned ADH-catalysed oxidative lactonisation (Scheme 15). [50] Here 2,2,6,6-tetramethylpiperidinoxyl (TEMPO) serves as ac hemical oxidant for the hydroxyl/lactol group and is itself regenerated aerobically by laccases.
This methodology may be of interest especially for the lactonisationo fr acemic diols to racemic lactones.H ere, the usually valued high stereoselectivity of enzymes mayb ecome an issue due to lowered conversion because of the KR character of the ADH-reaction.
Biocatalytic reductive lactonisations
While the aforementioned methodologies have been oxidative, also reductive lactonisation of g-keto acid(ester)s,e specially the fructose-derived levulinic acid, has received some attention.
Hilterhaus, Liese and co-workersf or example designed ar eaction cascade transformingl evulinic acid into (S)-g-valerolactone (Scheme 16). [51] Using stereocomplementary ADHs, Lavandera, Gotor and coworkers broadened the scope of this reaction to both enantiomers of g-a nd d-lactones. [52] More recently,t he same group also reportedt he synthesis of g-a nd d-lactames by substituting the ADH-catalysed ketoreductionb ya nw-transaminase-catalysed reductive amination (Scheme 17) of g-o rd-ketoesters. [53] Scheme13. Application of the 2LPS approach in oxidative lactonisation reactions.
Scheme14. Ac onvergent, redox-neutralcascade combining an ADH and a BVMO for the synthesis of e-caprolactone. [49b,c] Scheme15. TEMPO-catalysed oxidativel actonisation of 1,5-diols with aerobic, laccase-catalysed regeneration of TEMPO. [50] Scheme16. Chemoenzymatic cascade transforming levulinicacid into enantiomerically pure (S)-g-valerolactone. CPCR2: Carbonylr eductase 2f rom Candida parapsilosis.
The followingt able (Table 4) shows some selected examples (but not all)r epresenting the reductive biocatalytic oxidations and reductivea minations (Scheme4).
Conclusions
Lactones andl actamsr epresent an important class of substances with aw ide range of applications in industry.A lthoughd iscoveredd ecades ago, enzymatic synthesis of these crucial buildingb locks has been receiving increased interestd uring the past few years. Not only do these biocatalytic routes offer an apparent green alternative to current chemical methods,a lternative regiomer synthesis as well as the superiore nantioselectvityd isplayed by these biocatalysts provide accesst oi mportantc hiral synthons not easily accessible through traditional chemicalr outes. The challenges related to substrate and product inhibition, poor enzymes tability and narrow substrate scope have been largely dealt with through modern molecular biologyt echniques and/orr eactione ngineering. Considering the redox-reactions, the required nicotinamide cofactors can be recycled by diverse efficient in situ regenerationm ethods including the redox-neutral cascades,w hich makes the use of enzymes also economically feasible.
We believe that the rediscovered (chemo)enzymatic synthesis of lactones and lactams will be one of the major focuses in biocatalysis with the aim of synthesis of these industriali ntermediates with highv olumetric productivities and economical as well as ecological efficiency. Scheme17. Reductive lactamisationofs ome g-o rd-ketoesters using stereocomplementary transaminases. Both enantiomers were obtained essentially enantiomerically pure. [53] Chem. Asian J. 
